[ADRO] Aduro Biotech, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 11 Change: 0.95 (9.45%)
Ext. hours: Change: 0 (0%)

chart ADRO

Refresh chart

Strongest Trends Summary For ADRO

ADRO is in the medium-term up 18% in 4 months. In the long-term down -95% below S&P in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities22.31 M Cash From Investing Activities-310 K Cash From Operating Activities-8.47 M Gross Profit
Net Profit-16.62 M Operating Profit-7.28 M Total Assets138.76 M Total Current Assets136.96 M
Total Current Liabilities40.72 M Total Debt1.1 M Total Liabilities51.05 M Total Revenue9.57 M
Technical Data
High 52 week8.8 Low 52 week2.42 Last close3.38 Last change-0.88%
RSI29.45 Average true range0.22 Beta1.32 Volume206.2 K
Simple moving average 20 days-11.46% Simple moving average 50 days-12.92% Simple moving average 200 days-26.13%
Performance Data
Performance Week-10.34% Performance Month-13.56% Performance Quart17.36% Performance Half-50.51%
Performance Year-52.39% Performance Year-to-date28.03% Volatility daily3.34% Volatility weekly7.47%
Volatility monthly15.31% Volatility yearly53.04% Relative Volume205.44% Average Volume530.81 K
New High New Low

News

2019-04-18 16:05:00 | Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors

2019-04-17 16:05:00 | Aduro Biotech Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting

2019-04-08 08:47:11 | What Kind Of Shareholders Own Aduro BioTech, Inc. NASDAQ:ADRO?

2019-04-01 08:00:00 | Aduro Biotech to Present at the H.C. Wainwright Global Life Sciences Conference

2019-03-27 10:48:02 | Lilly LLY Signs New Immunology Deal With Private Biotech

2019-03-07 08:00:00 | Aduro Biotech to Present at Two Upcoming Investor Conferences in March

2019-03-01 10:27:03 | The Meet Group MEET to Report Q4 Earnings: What's in Store?

2019-03-01 09:18:37 | What Should We Expect From Aduro BioTech, Inc.’s NASDAQ:ADRO Earnings In The Years Ahead?

2019-02-28 16:13:09 | Aduro ADRO Q4 Earnings and Revenues Fall Shy of Estimates

2019-02-28 09:07:02 | Top Ranked Momentum Stocks to Buy for February 28th

2019-02-28 08:00:00 | Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019

2019-02-27 16:05:00 | Aduro Biotech Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-27 09:36:02 | Top Ranked Momentum Stocks to Buy for February 27th

2019-02-25 09:10:02 | Will Aduro Biotech Continue to Surge Higher?

2019-02-25 09:02:02 | What's in Store for Universal Health UHS Q4 Earnings?

2019-02-25 07:26:12 | Top Ranked Momentum Stocks to Buy for February 25th

2019-02-22 16:43:09 | What's in Store for Vericel VCEL This Earnings Season?

2019-02-21 08:55:01 | Will Difficult Comparison Hurt Bio-Rad's BIO Q4 Earnings?

2019-02-21 08:15:00 | Aduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-21 08:00:00 | Aduro Announces Changes to its Board of Directors

2019-02-20 08:54:01 | Will Hospice Strength Show on Amedisys' AMED Q4 Earnings?

2019-02-20 07:35:12 | What's in Store for Tandem Diabetes' TNDM Q4 Earnings?

2019-02-19 10:07:03 | What's in Store for Sangamo SGMO This Earnings Season?

2019-02-14 10:45:03 | The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna

2019-02-14 07:35:00 | Consolidated Research: 2019 Summary Expectations for The Trade Desk, Aduro Biotech, Walker & Dunlop, California Resources, Century Casinos, and Arsanis — Fundamental Analysis, Key Performance Indications

2019-02-14 06:49:11 | Will Aduro Biotech Continue to Surge Higher?

2019-02-13 08:36:01 | 5 Tiny Biotech Stocks With Superb Growth Potential

2019-02-12 18:29:11 | Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100

2019-02-11 16:51:09 | Zoetis ZTS to Report Q4 Earnings: What's in the Cards?

2019-02-11 09:39:02 | Merrimack MACK Stock Up Year to Date: Is a Rebound Likely?

2019-02-11 08:00:00 | Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 MIW815 in Combination with YERVOY ipilimumab for the Treatment of Relapsed and Refractory Melanoma

2019-02-08 10:00:03 | AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates

2019-02-07 06:19:11 | Will Aduro Biotech Continue to Surge Higher?

2019-02-06 09:38:02 | Top Ranked Momentum Stocks to Buy for February 6th

2019-01-30 23:45:02 | Why are deep-pocketed biotechs cutting hundreds of jobs?

2019-01-30 08:00:00 | Aduro Biotech Announces Strategic Reset

2019-01-25 13:33:24 | Is Aduro BioTech, Inc. NASDAQ:ADRO A Volatile Stock?

2019-01-24 14:20:07 | Athersys' ATHX MultiStem Cell Therapy Succeeds in Study

2019-01-24 10:46:03 | Vertex Terminates COO Ian Smith on Code of Conduct Violation

2019-01-24 10:08:03 | Amicus FOLD Boasts Strong Pipeline Amid Stiff Competition

2019-01-22 09:31:02 | Vertex's Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids

2019-01-21 09:09:02 | Aduro Biotech ADRO Upgraded to Strong Buy: What Does It Mean for the Stock?

2019-01-03 08:00:00 | Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference

2018-12-24 09:53:06 | Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more

2018-12-20 11:18:22 | What You Must Know About Aduro BioTech, Inc.’s NASDAQ:ADRO Financial Strength

2018-12-20 10:13:03 | The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte

2018-12-20 06:50:00 | Today's Research Reports on Trending Tickers: Aduro BioTech and Adial Pharmaceuticals

2018-12-19 12:30:00 | These 4 Pharma Stocks Are Heating Up

2018-12-19 10:23:03 | Aduro Stock Surges on STING Activator Deal With Eli Lilly

2018-12-19 09:17:02 | Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY